Your opinion is required to help the Pharmaceutical Benefits Advisory Committee (PBAC) evaluate whether a new treatment should be funded for metastatic pancreatic cancer.
Read story ➞Our impact in 2023 is due to the support of our entire community. Thank you
Read story ➞An overview of key areas of focus for the PanKind research program in 2023, including exciting developments from our Early Detection Initiative.
Read story ➞